Spots Global Cancer Trial Database for Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
Official Title: A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Study ID: NCT01494506
Conditions
Study Description
Brief Summary: The study is an open label, randomized phase 3 study of MM-398 with or without 5-Fluorouracil (5-FU) and Leucovorin (also known as folinic acid), versus 5-FU and leucovorin in metastatic pancreatic cancer patients who have progressed on prior gemcitabine based therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Gilbert, Arizona, United States
, Glendale, Arizona, United States
, Scottsdale, Arizona, United States
, Burbank, California, United States
, Duarte, California, United States
, Fresno, California, United States
, LaVerne, California, United States
, San Luis Obispo, California, United States
, Boyton Beach, Florida, United States
, Atlanta, Georgia, United States
, Kansas City, Missouri, United States
, St Louis, Missouri, United States
, Henderson, Nevada, United States
, Albuquerque, New Mexico, United States
, Buffalo, New York, United States
, Columbus, Ohio, United States
, Norman, Oklahoma, United States
, Greenville, South Carolina, United States
, Bedford, Texas, United States
, Dallas, Texas, United States
, Tyler, Texas, United States
, Fairfax, Virginia, United States
, Norfolk, Virginia, United States
, Buenos Aires, , Argentina
, Rosario, , Argentina
, Santa Fe, , Argentina
, Westmead, New South Wales, Australia
, Kurralta Park, South Australia, Australia
, Boxhill, Victoria, Australia
, Heidelberg, Victoria, Australia
, Melbourne, Victoria, Australia
, Nedlands, Western Australia, Australia
, Belo Horizonte, , Brazil
, Ijui, , Brazil
, Passo Fundo, , Brazil
, Porto Alegre, , Brazil
, Sao Paulo, , Brazil
, Montreal, Quebec, Canada
, Horovice, , Czech Republic
, Olomouc, , Czech Republic
, Prague, , Czech Republic
, Pribram, , Czech Republic
, Bordeaux, , France
, Lille, , France
, Marseille, , France
, Berlin, , Germany
, Jens, , Germany
, Munich, , Germany
, Ulm, , Germany
, Budapest, , Hungary
, Pecs, , Hungary
, Szeged, , Hungary
, Szolnok, , Hungary
, Szombathely, , Hungary
, Castellana Grotte, , Italy
, Genova, , Italy
, Legnano, , Italy
, Naples, , Italy
, Roma, , Italy
, Hwasun-gun, , Korea, Republic of
, Seoul, , Korea, Republic of
, Port Elizabeth, , South Africa
, Pretoria, , South Africa
, Western Cape, , South Africa
, Alicante, , Spain
, Barcelona, , Spain
, Madrid, , Spain
, Santander, , Spain
, Valencia, , Spain
, Chiayi, , Taiwan
, Kaohsiung, , Taiwan
, Taiching, , Taiwan
, Tainan, , Taiwan
, Taipei, , Taiwan
, Taoyuan, , Taiwan
, Liverpool, , United Kingdom
, London, , United Kingdom
, Manchester, , United Kingdom
, Sutton, , United Kingdom
Contact Details
Name: Eliel Bayever, MD
Affiliation: Merrimack Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
